Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Bioenvision Files for Drug OK in Europe (Reuters) Reuters - Bioenvision Inc. (BIVN.O) said on\Friday it has submitted an application to European regulators\to market its experimental leukemia drug.
